Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-018315

Dianthus Therapeutics, Inc. /DE/ · DNTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 25, 2018
Accepted (ET)
Jun 27, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001690585

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jun 25, 2018C0—A0ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF4,F2,F3,F5—Jun 25, 2018C0D——Common Stock00I
Series B Preferred StockF4,F2,F3,F5—Jun 25, 2018C0D——Common Stock00I

Explanation of responses